Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2024, Humana (HUM) reported revenue of $29.38 billion, up 14.2% over the same period last year. EPS came in at $6.96, compared to $8.94 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $28.63 billion, representing a surprise of +2.61%. The company delivered an EPS surprise of +18.17%, with the consensus EPS estimate being $5.89.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Benefits Expense Ratio - Consolidated

  : 89% versus 88.9% estimated by seven analysts on average.

• Medical Membership - Group Medicare Advantage

  : 544.9 thousand compared to the 551.66 thousand average estimate based on five analysts.

• Medical Membership - Medicare stand-alone PDP

  : 2.34 million versus the five-analyst average estimate of 2.29 million.

• Medical Membership - Individual Medicare Advantage

  : 5.62 million compared to the 5.55 million average estimate based on five analysts.

• Revenues- Premiums

  : $28.14 billion compared to the $27.21 billion average estimate based on eight analysts. The reported number represents a change of +10.4% year over year.

• Revenues- Investment income (loss)

  : $298 million versus the eight-analyst average estimate of $304.69 million. The reported number represents a year-over-year change of +8.8%.

• Revenues- Services

  : $1.10 billion versus the seven-analyst average estimate of $988.45 million. The reported number represents a year-over-year change of +12.5%.

• Revenue- CenterWell

  : $4.95 billion versus $4.80 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +9.2% change.

• Revenues- Consolidated- Premiums- Specialty benefits

  : $240 million compared to the $243.90 million average estimate based on five analysts. The reported number represents a change of -4.8% year over year.

• Revenue- Insurance

  : $28.53 billion versus the five-analyst average estimate of $27.54 billion. The reported number represents a year-over-year change of +10.2%.

• Insurance segment - Intersegment revenues- Services

  : $1 million versus the five-analyst average estimate of $4.60 million.

• Insurance segment- Investment income

  : $168 million versus the five-analyst average estimate of $157.10 million.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Humana Inc. (HUM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research